What the trials showed
In SURMOUNT-1, average weight loss rose with dose – roughly 15 percent of body weight at 5 mg up to about 21 percent at 15 mg over 72 weeks. Averages, not guarantees: responses ranged widely at every dose.
Why nobody starts at the top
The 2.5 mg starting dose exists to build tolerance, not to produce results. Stepping up every four weeks lets your clinician find the dose where appetite control is solid and side effects are quiet – which for many people is 5 or 10 mg, not 15.
The plateau question
If progress stalls, a dose increase is one tool – but so are holding longer, checking nutrition, and reviewing sleep and stress. Up is not the only direction that restarts progress.
Approval status for every brand product is verifiable in Drugs@FDA.
The compliance line
Dosing is individualized by a licensed clinician against your history and response. Never adjust your own dose or stack pens to approximate a higher one. See the 30-second film answers for this medication.
What a titration schedule is actually for
Titration means starting at a dose below the one intended to be effective and stepping up on a schedule. It exists for tolerability, not caution for its own sake. Receptor signalling that arrives gradually gives the gut time to adapt, which is why the label sets minimum intervals between increases rather than leaving the pace open. Skipping ahead does not accelerate anything except side effects. Holding at a dose is a legitimate clinical decision, and so is stepping back down. If you want the lower end of that range as a deliberate plan rather than a waypoint, that is what microdosing describes. Your clinician sets the schedule, reviews how you are tolerating it, and adjusts. Nothing about a titration plan guarantees a particular result, and no schedule substitutes for the follow-up conversation that decides whether to continue.
How tirzepatide works on two receptors at once
Tirzepatide is a single molecule that activates two incretin receptors: GIP and GLP-1. Both are receptors your gut already uses. After a meal, the intestine releases incretin hormones that tell the pancreas to release insulin, slow how fast the stomach empties, and signal fullness to the hypothalamus. Tirzepatide binds those same receptors, so the signal is present at a steadier level than it would be from food alone. The GLP-1 arm is the one most people have heard of. The GIP arm is what distinguishes tirzepatide from semaglutide, which acts on GLP-1 only. According to the FDA prescribing information for tirzepatide products, dual agonism is the mechanism of record. What that difference means for any individual is a clinical question, not a settled one, and a licensed clinician decides whether the medication is appropriate for you at all.
What compounded means, and what it does not
A compounded preparation is made by a licensed pharmacy for an individual patient on receipt of a valid prescription. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. That is a statement about regulatory pathway, not an accusation about any particular pharmacy, and it is why the distinction matters more than marketing language does. A compounded preparation is not a generic and not an equivalent of any FDA-approved brand product. Published clinical trials such as SURMOUNT-1 studied the branded product at studied doses; those findings should not be assumed to transfer. What compounded means unpacks the legal framework, and red flags when buying online covers how to tell a legitimate pharmacy from a grey-market seller.
Why side effects are mostly digestive, and mostly early
Because the receptors tirzepatide acts on sit in the gut and the brainstem, the predictable effects are digestive: nausea, reflux, constipation, diarrhoea, and a feeling of fullness that arrives sooner than expected. According to FDA prescribing information for tirzepatide products, gastrointestinal reactions are the most commonly reported adverse events, and they are dose-related for many people. The practical implication is that they tend to cluster around a dose change rather than persist indefinitely. Serious risks are listed separately in the label, including pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumours in rodents. Those are not common, but they are the reason the medication is prescription-only. Report severe or persistent abdominal pain, vomiting that stops you keeping fluids down, or vision changes to your clinician promptly rather than waiting for a scheduled check-in.
About 10 minutes. Full refund if nothing is prescribed.
Frequently asked questions
Is 15 mg always better than 5 mg?
On trial averages, higher doses lost more – but individually, the best dose is the lowest one that works for you. Side effects scale with dose too.
How long until my dose 'works'?
Give each dose several weeks; levels and effects build. Judging a dose in week one is premature.
Can I stay on a middle dose forever?
Yes – maintenance at the dose that holds your progress is a normal, clinician-approved strategy.
Is compounded tirzepatide the same as Zepbound?
No. Zepbound is an FDA-approved product; a compounded preparation is made by a licensed pharmacy for an individual patient and is not FDA-approved. FDA does not review compounded preparations for safety, effectiveness, or quality before marketing, and a compounded preparation is not a generic or an equivalent.
What is the starting dose of compounded tirzepatide?
Your prescribing clinician sets the starting dose and the titration schedule, and the dispensing pharmacy supplies instructions for your specific concentration. There is no single published starting dose for compounded preparations, and units and milligrams are not interchangeable.
How long can compounded tirzepatide be out of the fridge?
Follow the storage instructions supplied with your preparation, because the permitted excursion window depends on the exact formulation. If a package arrives warm, leaking, cloudy, or damaged, contact the dispensing pharmacy rather than using it.
Find the dose that fits you – not the forum
A licensed clinician reviews your history and decides what is appropriate. Rx only, refunded in full if you are not prescribed.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- Peer-reviewedJastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022;387:205-216
- FDAFDA prescribing information: Zepbound (dosage)
- FDA databaseDrugs@FDA: search approved labeling for tirzepatide
- Peer-reviewedSURMOUNT-1: Tirzepatide Once Weekly for the Treatment of Obesity (NEJM 2022)
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on Brand-Name Pens
Same medication, different question.
